Results 191 to 200 of about 42,523 (291)
Antagonism of acute cocaine toxicity by buprenorphine
, 1991 Vijay K. Shukla +3 more
openalex +1 more source
Addiction, EarlyView.Abstract Background and aims People with opioid use disorder are at increased risk of intentional self‐harm and suicide. Although risk factors are well known, most tools for identifying individuals at highest risk of these behaviours have limited clinical value.
Nicola R. Jones +7 more
wiley +1 more source
Addiction, EarlyView.Abstract Background and aims An investigation of 24 weeks of extended‐release buprenorphine (BUP‐XR; Sublocade®) treatment for adults with opioid use disorder (OUD). Study aims were to characterise variations in clinical response, investigate personal factors influencing BUP‐XR experience and identify opportunities to tailor treatment interventions ...
Natalie Lowry +13 more
wiley +1 more source
Room D, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Mutual Antagonism of Buprenorphine and Morphine as Evidenced in the Nociceptive Activity Evoked in Thalamus Neurons of the Rat [PDF]
, 2000 Alexander Nemirovsky, Ilmar Jurna Med
openalex +1 more source
Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage +3 more
wiley +1 more source
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Xylazine, an alpha‐2‐adrenergic agonist, has been increasingly implicated in substance use and overdose crises. However, little is known about its effects on humans. With the growing public health crisis surrounding xylazine, it has become important to recognize and promptly manage symptoms of xylazine toxicity ...
Philipa Owusu‐Antwi +4 more
wiley +1 more source
Preparation of Buprenorphine Sublingual Tablets and Clinical Effects.
, 1994 Michiteru Ohtani +5 more
openalex +2 more sources
Alimentary Pharmacology &Therapeutics, EarlyView.Prevalence of opioid use among adults with CD is high 2 years before and remains high 5 years after the 1st CD diagnosis. The use of opioids among adults with CD and reference individuals in Sweden has declined 2008–2021. ABSTRACT Background and Aims Population‐based data on prescribed opioid use among adults with Crohn's disease (CD) remain limited ...
Mehdi Osooli +17 more
wiley +1 more source
Plasma concentrations of buprenorphine 24 to 72 hours after dosing
, 1999 Marek C. Chawarski +3 more
openalex +1 more source